Related Experiment Video
Updated: Mar 13, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.3K
Polymyalgia Rheumatica
Christian Dejaco1,2, Eric L Matteson3
1Department of Rheumatology, Medical University Graz, Graz, Austria.
The New England Journal of Medicine
|March 11, 2026
Summary
Polymyalgia rheumatica is an inflammatory disease causing shoulder and hip pain in adults over 50. Treatment involves glucocorticoids, with relapses sometimes requiring other medications to reduce steroid use.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Polymyalgia rheumatica (PMR) is an inflammatory condition affecting individuals over 50.
- Characterized by shoulder pain, hip pain, neck pain, and morning stiffness.
- Diagnosis relies on symptoms, elevated inflammatory markers (ESR, CRP), and exclusion of other conditions like giant-cell arteritis.
Purpose of the Study:
- To summarize the key aspects of polymyalgia rheumatica.
- To outline diagnostic criteria and primary treatment strategies.
- To discuss disease course, relapse management, and alternative therapies.
Main Methods:
- Literature review of polymyalgia rheumatica diagnosis and management.
- Analysis of hallmark symptoms and diagnostic markers.
- Evaluation of treatment protocols, including glucocorticoids and alternative medications.
Main Results:
- PMR diagnosis is based on specific symptoms, elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels.
- Glucocorticoids are the first-line treatment, providing rapid symptom relief.
- Disease duration varies, relapses are frequent, necessitating strategies to minimize glucocorticoid exposure.
Conclusions:
- Polymyalgia rheumatica requires prompt diagnosis and management, primarily with glucocorticoids.
- Long-term management may involve adjusting medication to minimize steroid toxicity.
- Interleukin-6 receptor inhibitors or methotrexate are considered for relapsing cases or to reduce glucocorticoid dependence.
Related Concept Videos
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
878
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
878
01:23Rheumatic Heart Disease I: Introduction
717
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
717
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
714
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
714
01:20Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
01:27Myocarditis II: Clinical Features and Diagnostic Tests
399
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
399
01:21Rheumatic Heart Disease III: Medical Management
450
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
450